| Literature DB >> 28841191 |
Jian-Ye Zhang1, Wen-Jing Huang2, Hong-Mei Sun3, Yun Liu4, Xiao-Qin Zhao5, Si-Li Tang6, Ming-Na Sun7, Sheng Wang8, Jia-Jun Li9, Ling-Ling Zhang10, Jun-Hua Zhou11, Qian-Rong Pan12, Hu-Biao Chen13.
Abstract
Natural products from the genus Euphorbia show attention-attracting activities, such as anticancer activity. In this article, classical isolation and structure identification were used in a study on Caper Euphorbia Seed. Subsequently, MTT and wound healing assays, flow cytometry, western blotting, Hoechst 33258 staining and fluorescence microscopy examination were applied to investigate the anticancer activity of the obtained compounds. In a result, lathyrol-3-phenyl- acetate-5,15-diacetate (deoxy Euphorbia factor L1, DEFL1) was isolated from Caper Euphorbia Seed. Moreover, the NMR signals were totally assigned. DEFL1 showed potent inhibition against lung cancer A549 cells, with an IC50 value of 17.51 ± 0.85 μM. Furthermore, DEFL1 suppressed wound healing of A549 cells in a concentration-dependent manner. Mechanically, DEFL1 induced apoptosis, with involvement of an increase of reactive oxygen species (ROS), decrease of mitochondrial membrane potential (ΔΨm), release of cytochrome c, activity raise of caspase-9 and 3. Characteristic features of apoptosis were observed by fluorescence microscopy. In summary, DEFL1 inhibited growth and induced apoptosis in lung cancer A549 cells via a mitochondrial pathway.Entities:
Keywords: Caper Euphorbia Seed; apoptosis; diterpenoids; lathyrol-3-phenylacetate-5,15-diacetate; lung cancer; natural products
Mesh:
Substances:
Year: 2017 PMID: 28841191 PMCID: PMC6151716 DOI: 10.3390/molecules22091412
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
1H- and 13C-NMR data of DEFL1 (δ, CDCl3, 500 and 125 MHz for 13C and 1H, respectively).
| Position | 13C | 1H | HMBC (H→C) | |
|---|---|---|---|---|
| 1 | 48.3 | 3.40 (1H, dd, | 2, 3, 4, 14, 15 | |
| 2 | 37.4 | 2.01 (1H, m) | 1, 3, 4, 15, 16 | |
| 3 | 80.6 | 5.60 (1H, t, | 1, 1’, 15 | |
| 4 | 52.2 | 2.79 (1H, dd, | 5, 6, 14 | |
| 5 | 65.9 | 6.12 (1H, d, | 4, 6, 7, 15, 5-CO | |
| 6 | 144.4 | |||
| 7 | 35.0 | 2.11 (1H, m), 2.20 (1H, m) | 5, 6, 8, 9, 17 | |
| 8 | 21.7 | 2.01 (1H, m), 1.71 (1H, m) | 6, 9 | |
| 9 | 35.3 | 1.1 (1H , m) | 18, 19 | |
| 10 | 25.2 | |||
| 11 | 29.0 | 1.40 (1H, dd, | 9, 10, 12, 13 | |
| 12 | 146.7 | 6.54 (1H, d, 11.2 Hz) | 9, 14, 20 | |
| 13 | 134.1 | |||
| 14 | 196.8 | |||
| 15 | 92.3 | |||
| 16 | 13.7 | 0.73 (3H, d, | 1, 2, 3 | |
| 17 | 115.6 | 5.01 (1H, s), 4.74 (1H, s) | 5, 6, 7 | |
| 18 | 28.4 | 1.19 (3H, s) | 9, 10, 11, 19 | |
| 19 | 16.8 | 1.18 (3H, s) | 9, 10, 11, 18 | |
| 20 | 12.4 | 1.70 (3H, s) | 12, 13, 14 | |
| 5-COCH3 | CH3 | 21.3 | 1.96 (3H, s) | 5-CO |
| CO | 170.7 | |||
| 15-COCH3 | CH3 | 22.0 | 2.20 (3H, s) | 15-CO |
| CO | 169.8 | |||
| 3-OPhAc | 1′ | 171.3 | ||
| 2’ | 41.6 | 3.64 (1H, d, | 1′, 3′, 4′, 8′ | |
| 3′ | 134.0 | |||
| 6′ | 127.1 | 7.25 (1H, m) | 4′, 8′ | |
| 4′, 8′ | 129.5 | 7.31 (2H, m) | 2’, 3′ | |
| 5′, 7′ | 128.5 | 7.33 (2H, m) | 3′ | |
Figure 1(A) Chemical structure of lathyrol-3-phenylacetate-5,15-diacetate (deoxy Euphorbia factor L1, DEFL1); (B) Growth inhibition curve of DEFL1 against A549, KB and HCT116 cells.
Figure 2DEFL1 inhibition of A549 cells growth and migration. (A) Microscopic observation of A549 cells wound healing results after treatment of different concentrations for the indicated time; (B) Statistical analysis results of different concentration groups compared at 12, 24 and 48 h, respectively.** p < 0.01.
Figure 3DEFL1 treatment led to an increase of ROS levels in A549 cells in a time-course manner. (A) ROS generation increase was observed after exposured to 18.0 μM DEFL1 for the indicated time; (B) Intracellular ROS levels of A549 cells is expressed as a percentage of control. ** p < 0.01.
Figure 4Decrease of ΔΨm was observed after A549 cells were exposed to DEFL1 showing a time-dependent pattern. (A) Reduction of ΔΨm measured by flow cytometry; (B) A549 cells ΔΨm at different time was expressed as a percentage of control. ** p < 0.01.
Figure 5Exposure to DEFL1 resulted in release of cytochrome c. (A) Western blotting results of cytochrome c after various time of treatment; (B) Relative gray values of western blotting results were determined by Image J. ** p < 0.01.
Figure 6Caspase-9, -3 were activated and apoptosis character of Hoechst 33258 staining was observed. (A) Activities of caspase-9 and -3 in A549 cells were significantly enhanced by DEFL1 in time-dependent manner; (B) Hoechst 33258 staining confirmed the apoptosis, displaying morphological changes of apoptosis. ** p < 0.01.
Figure 7Proposed mechanism of DEFL1 regarding apoptosis inducement in A549 cells.